628
Participants
Start Date
October 21, 2019
Primary Completion Date
October 10, 2023
Study Completion Date
October 10, 2023
Gepotidacin
Gepotidacin will be administered as 3000 milligram (mg) oral dose (4 X 750 mg tablets) at the study site followed by 3000 mg oral dose (4 X 750 mg tablets) as an outpatient. Each dose should be taken after food consumption and with water.
Ceftriaxone
Ceftriaxone is available as sterile powder for reconstitution. It will be administered as one 500-mg IM dose at the study site.
Azithromycin
Azithromycin will be administered as 1000 mg oral dose (2 X 500 mg tablets) at the study site. Dose should be taken after food consumption and with water.
GSK Investigational Site, Darlinghurst
GSK Investigational Site, Darlinghurst, Sydney
GSK Investigational Site, Carlton
GSK Investigational Site, Prahran
GSK Investigational Site, Southport
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Hamburg
GSK Investigational Site, Greensboro
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Madrid
GSK Investigational Site, Decatur
GSK Investigational Site, DeLand
GSK Investigational Site, Orlando
GSK Investigational Site, Seville
GSK Investigational Site, Cleveland
GSK Investigational Site, Guadalajara
GSK Investigational Site, Guadalajara
GSK Investigational Site, Indianapolis
GSK Investigational Site, Bilbao
GSK Investigational Site, Cologne
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Frankfurt am Main
GSK Investigational Site, Monterrey
GSK Investigational Site, New Orleans
GSK Investigational Site, Longview
GSK Investigational Site, Houston
GSK Investigational Site, München
GSK Investigational Site, Munich
GSK Investigational Site, Los Angeles
GSK Investigational Site, Palm Springs
GSK Investigational Site, Springfield
GSK Investigational Site, Fayetteville
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Barcelona
GSK Investigational Site, Birmingham
GSK Investigational Site, Brighton
GSK Investigational Site, Edinburgh
GSK Investigational Site, Leeds
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, London
GSK Investigational Site, Manchester
GSK Investigational Site, Reading
GSK Investigational Site, St Helens
Lead Sponsor
GlaxoSmithKline
INDUSTRY